Clinical Trial Update: Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to evaluate tacrolimus in combination with rituximab as initial therapy for Minimal Change Disease; the study status is NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Change Disease

Drugs mentioned

• Rituximab (rituximab)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Minimal Change Disease | Phase 3 | Status: NOT_YET_RECRUITING